Device Closure of Patent Foramen Ovale after Stroke: Pooled Analysis of Completed Randomized Trials

Journal of the American College of Cardiology

Volumn 67, Issue 8, 2016, Pages 907-917

  Kent, David M ^a,b   Dahabreh, Issa J ^a,c   Ruthazer, Robin ^a   Furlan, Anthony J ^d   Reisman, Mark ^e   Carroll, John D ^f   Saver, Jeffrey L ^g   Smalling, Richard W ^h   Jüni, Peter ^i,j   Mattle, Heinrich P ^k   Meier, Bernhard ^k   Thaler, David E ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ UNIVERSITY OF BERN   (Switzerland)

^j ST MICHAEL'S HOSPITAL   (Canada)

^k UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

cryptogenic stroke; meta analysis; transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE; WARFARIN;

ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; HEART DEATH; HUMAN; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPTAL OCCLUDER; TRANSIENT ISCHEMIC ATTACK; ADVERSE EFFECTS; COMPLICATION; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; INCIDENCE; META ANALYSIS; PROCEDURES; PROSTHESIS FAILURE; STROKE; SURVIVAL RATE; TRENDS; UNITED STATES;

CARDIAC CATHETERIZATION; FORAMEN OVALE, PATENT; HUMANS; INCIDENCE; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPTAL OCCLUDER DEVICE; STROKE; SURVIVAL RATE; UNITED STATES;

EID: 84958977345     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.12.023     Document Type: Article

References (31)

1. G.D. Kitsios, D.E. Thaler, and D.M. Kent Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials Stroke 44 2013 2640 2643
2. A.R. Khan, A.A. Bin Abdulhak, M.A. Sheikh, and et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis J Am Coll Cardiol Intv 6 2013 1316 1323
3. A.M. Pineda, F.O. Nascimento, S.C. Yang, and et al. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events Catheter Cardiovasc Interv 82 2013 968 975
4. F.A. Spencer, L.C. Lopes, S.A. Kennedy, and G. Guyatt Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale BMJ Open 4 2014 e004282
5. S. Stortecky, B.R. da Costa, H.P. Mattle, and et al. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis Eur Heart J 36 2015 120 128
6. A.J. Furlan, M. Reisman, J. Massaro, and et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale N Engl J Med 366 2012 991 999
7. J.D. Carroll, J.L. Saver, D.E. Thaler, and et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke N Engl J Med 368 2013 1092 1100
8. B. Meier, B. Kalesan, H.P. Mattle, and et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism N Engl J Med 368 2013 1083 1091
9. R.D. Riley, P.C. Lambert, and G. Abo-Zaid Meta-analysis of individual participant data: rationale, conduct, and reporting BMJ 340 2010 c221
10. A.V. Hernandez, M.J. Eijkemans, and E.W. Steyerberg Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power? Ann Epidemiol 16 2006 41 48
11. A.V. Hernandez, E.W. Steyerberg, and J.D. Habbema Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements J Clin Epidemiol 57 2004 454 460
12. D.M. Kent, T.A. Trikalinos, and M.D. Hill Are unadjusted analyses of clinical trials inappropriately biased toward the null? Stroke 40 2009 672 673
13. R.L. Sacco, R. Adams, G. Albers, and et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke Stroke 37 2006 577 617
14. R.L. Sacco, S.E. Kasner, J.P. Broderick, and et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 44 2013 2064 2089
15. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
16. D.R. Cox Regression models and life-tables J R Stat Soc Series B Stat Methodol 34 1972 187 220
17. D.M. Kent, and D.E. Thaler The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke Trials 12 2011 185
18. D.M. Kent, R. Ruthazer, C. Weimar, and et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke Neurology 81 2013 619 625
19. D.E. Thaler, R. Ruthazer, C. Weimar, and et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs Neurology 83 2014 221 226
20. M.L. Mono, L. Geister, A. Galimanis, and et al. Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events Stroke 42 2011 2891 2895
21. W.N. Kernan, B. Ovbiagele, H.R. Black, and et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 45 2014 2160 2236
22. J. Lau, E.M. Antman, J. Jimenez-Silva, and et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction N Engl J Med 327 1992 248 254
23. P.C. Austin, A. Manca, M. Zwarenstein, and et al. A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals J Clin Epidemiol 63 2010 142 153
24. M. Taaffe, E. Fischer, A. Baranowski, and et al. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder) Am J Cardiol 101 2008 1353 1358
25. M. Hornung, S.C. Bertog, J. Franke, and et al. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale Eur Heart J 34 2013 3362 3369
26. I.B. Riaz, A. Dhoble, A. Mizyed, and et al. Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials BMC Cardiovasc Disord 13 2013 116
27. A. Hakeem, K. Marmagkiolis, Y. Hacioglu, and et al. Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: comprehensive systematic review and meta-analysis of randomized controlled trials Cardiovasc Revasc Med 14 2013 349 355
28. D. Capodanno, G. Milazzo, L. Vitale, and et al. Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies EuroIntervention 9 2014 1342 1349
29. D.M. Kent, I.J. Dahabreh, R. Ruthazer, and et al. Anticoagulant versus antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis Euro Heart J 36 2015 2381 2389
30. B.M. Psaty, and R.L. Prentice Minimizing bias in randomized trials: the importance of blinding JAMA 304 2010 793 794
31. A. Wahl, P. Juni, M.L. Mono, and et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism Circulation 125 2012 803 812